Lessons learned from the development of a hidradenitis suppurativa xenograft mouse model
Authors:
- 19 July 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 45 (2) , 202-206
Abstract
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease originating from the pilosebaceous unit, in which patients develop painful abscesses, sinus tracts, nodules and scarring, typically in intertriginous areas. Major gaps in our understanding of HS exist, and these may be partially due to the lack of an animal model for experimental studies. We developed an HS xenograft mouse model using human HS lesions grafted onto immunocompromised mice. Although the model had its limitations, several informative lessons were learned, which may contribute to future attempts at an HS animal model.Keywords
Funding Information
- Valeant Pharmaceuticals International (Johns Hopkins Ethnic Skin Fellowship)
This publication has 10 references indexed in Scilit:
- Research Techniques Made Simple: Murine Models of Human PsoriasisJournal of Investigative Dermatology, 2018
- Human reconstructed skin xenografts on mice to model skin physiologyDifferentiation, 2017
- Major gaps in understanding and treatment of hidradenitis suppurativaSeminars in Cutaneous Medicine and Surgery, 2017
- Pathophysiology of hidradenitis suppurativaSeminars in Cutaneous Medicine and Surgery, 2017
- Epidemiologic and clinical features of hidradenitis suppurativaSeminars in Cutaneous Medicine and Surgery, 2017
- Animal Models for Alopecia Areata: What and Where?Journal of Investigative Dermatology Symposium Proceedings, 2015
- Melanocytes as Instigators and Victims of Oxidative StressJournal of Investigative Dermatology, 2014
- Can Animal Skin Diseases or Current Transgenic Mice Serve as a Model for Hidradenitis Suppurativa?Dermatology, 2012
- Translating clinical activity and gene expression signatures of etanercept and ciclosporin to the psoriasis xenograft SCID mouse modelBritish Journal of Dermatology, 2011
- AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3Leukemia, 2010